Works matching IS 03125963 AND DT 2024 AND VI 63 AND IP 12

Results: 12
    1
    2

    A Population Pharmacokinetic Study to Evaluate Doxorubicin Exposure Across All Age Groups: Effect of Age on the Pharmacokinetics of Doxorubicin: M. I. M. Ali et al.

    Published in:
    Clinical Pharmacokinetics, 2024, v. 63, n. 12, p. 1711, doi. 10.1007/s40262-024-01445-5
    By:
    • Mohmaed Ali, Ma Ida;
    • Nijstad, A. Laura;
    • Boosman, René J.;
    • Crombag, Marie-Rose B. S.;
    • Barnett, Shelby;
    • Veal, Gareth J.;
    • Lalmohamed, Arief;
    • van Erp, Nielka P.;
    • Steeghs, Neeltje;
    • Zwaan, C. Michel;
    • Beijnen, Jos H.;
    • Siebinga, Hinke;
    • Huitema, Alwin D. R.
    Publication type:
    Article
    3
    4
    5
    6

    Coupling Pre- and Postnatal Infant Exposures with Physiologically Based Pharmacokinetic Modeling to Predict Cumulative Maternal Levetiracetam Exposure During Breastfeeding: PBPK Modeling to Predict Infant Levetiracetam Exposure During Breastfeeding: S. V. Suryavanshi et al

    Published in:
    Clinical Pharmacokinetics, 2024, v. 63, n. 12, p. 1735, doi. 10.1007/s40262-024-01447-3
    By:
    • Suryavanshi, Santosh V.;
    • Wang, Shirley;
    • Hajducek, Dagmar M.;
    • Hamadeh, Abdullah;
    • Yeung, Cindy H. T.;
    • Maglalang, Patricia D.;
    • Ito, Shinya;
    • Autmizguine, Julie;
    • Gonzalez, Daniel;
    • Edginton, Andrea N.
    Publication type:
    Article
    7
    8

    Pharmacokinetics of Tarlatamab, a Delta-Like Ligand-3 (DLL3) Targeted Half-Life Extended Bispecific T-Cell Engager (BiTE<sup>®</sup>) Immunotherapy in Adult Patients with Previously Treated Small-Cell Lung Cancer: Results from DeLLphi-300, a Phase I Multiple-Dose-Escalation Study: Tarlatamab Pharmacokinetics in Patients with SCLC : M. Minocha et al

    Published in:
    Clinical Pharmacokinetics, 2024, v. 63, n. 12, p. 1757, doi. 10.1007/s40262-024-01451-7
    By:
    • Minocha, Mukul;
    • Thompson, Corbin G.;
    • Murphy, Alexis;
    • Zhou, Yanchen;
    • Brandl, Christian;
    • Parkes, Amanda;
    • Chen, Xi;
    • Yu, Brian;
    • Martinez, Pablo;
    • Houk, Brett E.
    Publication type:
    Article
    9
    10

    Pharmacokinetics of Antiretroviral Drugs in Older People Living with HIV, Part II: Drugs Licensed Before 2005: Impact of Aging on the Pharmacokinetics of Antiretrovirals Licensed before 2005: T. Toledo et al.

    Published in:
    Clinical Pharmacokinetics, 2024, v. 63, n. 12, p. 1655, doi. 10.1007/s40262-024-01441-9
    By:
    • Toledo, Thainá;
    • Oliveira, Vanessa G.;
    • Cattani, Vitória Berg;
    • Seba, Karine;
    • Veloso, Valdilea Gonçalves;
    • Grinsztejn, Beatriz;
    • Cardoso, Sandra Wagner;
    • Torres, Thiago S.;
    • Estrela, Rita
    Publication type:
    Article
    11
    12

    Population Pharmacokinetics of Intravenous Paracetamol and Its Metabolites in Extreme Preterm Neonates in the Context of Patent Ductus Arteriosus Treatment: Pharmacokinetics of Paracetamol and Its Metabolites in Preterm Neonates of 23–26 Weeks: F. Padavia et al

    Published in:
    Clinical Pharmacokinetics, 2024, v. 63, n. 12, p. 1689, doi. 10.1007/s40262-024-01439-3
    By:
    • Padavia, Faheemah;
    • Treluyer, Jean-Marc;
    • Cambonie, Gilles;
    • Flamant, Cyril;
    • Rideau, Aline;
    • Tauzin, Manon;
    • Patkai, Juliana;
    • Gascoin, Géraldine;
    • Lumia, Mirka;
    • Aikio, Outi;
    • Foissac, Frantz;
    • Urien, Saïk;
    • Benaboud, Sihem;
    • Lui, Gabrielle;
    • Froelicher Bournaud, Léo;
    • Zheng, Yi;
    • Kemper, Ruth;
    • Tortigue, Marine;
    • Baruteau, Alban-Elouen;
    • Kallio, Jaana
    Publication type:
    Article